PMID- 34150003 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210622 IS - 1943-8141 (Print) IS - 1943-8141 (Electronic) IS - 1943-8141 (Linking) VI - 13 IP - 5 DP - 2021 TI - Circular RNA circ_0084927 regulates proliferation, apoptosis, and invasion of breast cancer cells via miR-142-3p/ERC1 pathway. PG - 4120-4136 AB - OBJECTIVE: We aimed to investigate the mechanism of circular RNA circ_0084927 in the progression of breast cancer (BC). METHODS: The levels of circ_0084927, miR-142-3p, and ELKS/RAB6-interacting/CAST family member-1 (ERC1) mRNA in the BC tissues and cells were detected by qRT-PCR. CCK8, colony formation, Transwell, and flow cytometry assays were performed to examine the cell proliferation, colony formation, cell invasion, and apoptosis, respectively, in the BC cells with regulated expressions of circ_0084927, miR-142-3p, and ERC1. RNase R treatment was employed to verify the circular structure of circ_0084927. Nucleocytoplasmic separation experiment, bioinformatics analysis, dual-luciferase reporter assay, and RNA immunoprecipitation were performed to investigate the ceRNA mechanism of circ_0084927. RESULTS: High levels of circ_0084927 and ERC1 and low levels of miR-142-3p were detected in the BC tissues and cells. Knockdown of circ_0084927 promoted apoptosis and inhibited proliferation, colony formation, and invasion of BC cells (all P<0.05), whereas overexpression of circ_0084927 in the BC cells achieved the opposite effects. miR-142-3p is the target of circ_0084927. Overexpression of miR-142-3p could inhibit BC cell proliferation, colony formation, and cell invasion and induce apoptosis of the BC cells (all P<0.05), and the effects of miR-142-3p knockout on the BC cells could be reversed by silencing circ_0084927. miR-142-3p could target ERC1. Both ERC1 silencing and circ_0084927 knockout in the BC cells could achieve the tumor-suppressing effect, and this effect could be more remarkable under simultaneous ERC1 silencing and circ_0084927 knockout (all P<0.05). CONCLUSION: Circ_0084927 can promote the progression of BC by regulating the miR-142-3p/ERC1 axis. CI - AJTR Copyright (c) 2021. FAU - Gong, Guohua AU - Gong G AD - Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System Tongliao, Inner Mongolia Autonomous Region, China. AD - First Clinical Medical of Inner Mongolia University for Nationalities Tongliao, Inner Mongolia Autonomous Region, China. FAU - She, Jikai AU - She J AD - Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System Tongliao, Inner Mongolia Autonomous Region, China. AD - Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for The Nationalities Tongliao, Inner Mongolia Autonomous Region, China. FAU - Fu, Danni AU - Fu D AD - Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System Tongliao, Inner Mongolia Autonomous Region, China. AD - Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for The Nationalities Tongliao, Inner Mongolia Autonomous Region, China. FAU - Zhen, Dong AU - Zhen D AD - Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System Tongliao, Inner Mongolia Autonomous Region, China. AD - Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for The Nationalities Tongliao, Inner Mongolia Autonomous Region, China. FAU - Zhang, Bin AU - Zhang B AD - Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System Tongliao, Inner Mongolia Autonomous Region, China. AD - First Clinical Medical of Inner Mongolia University for Nationalities Tongliao, Inner Mongolia Autonomous Region, China. LA - eng PT - Journal Article DEP - 20210515 PL - United States TA - Am J Transl Res JT - American journal of translational research JID - 101493030 PMC - PMC8205726 OTO - NOTNLM OT - ELKS/RAB6-interacting/CAST family member-1 OT - breast cancer OT - circ_0084927 OT - miR-142-3p COIS- None. EDAT- 2021/06/22 06:00 MHDA- 2021/06/22 06:01 PMCR- 2021/05/15 CRDT- 2021/06/21 05:55 PHST- 2020/11/30 00:00 [received] PHST- 2021/02/09 00:00 [accepted] PHST- 2021/06/21 05:55 [entrez] PHST- 2021/06/22 06:00 [pubmed] PHST- 2021/06/22 06:01 [medline] PHST- 2021/05/15 00:00 [pmc-release] PST - epublish SO - Am J Transl Res. 2021 May 15;13(5):4120-4136. eCollection 2021.